Chemoinformaics analysis of 4-(4-Methyl-cyclohex-3-enyl)-pent-3-en-2-one
| Molecular Weight | 178.275 | nRot | 2 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 8 |
| Exact Molecular Weight | 178.136 | nRing | 1 |
| Solubility: LogS | -3.129 | nHRing | 0 |
| Solubility: LogP | 3.034 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.8443 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.468 |
| Synth | 3.326 |
| Natural Product Likeliness | 1.717 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.394 |
| MDCK | 0.0000272 |
| BBB | 0.195 |
| PPB | 0.950666 |
| VDSS | 2.543 |
| FU | 0.0461022 |
| CYP1A2-inh | 0.486 |
| CYP1A2-sub | 0.475 |
| CYP2c19-inh | 0.746 |
| CYP2c19-sub | 0.847 |
| CYP2c9-inh | 0.291 |
| CYP2c9-sub | 0.678 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.324 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.35 |
| CL | 5.978 |
| T12 | 0.689 |
| hERG | 0.008 |
| Ames | 0.017 |
| ROA | 0.011 |
| SkinSen | 0.94 |
| Carcinogencity | 0.944 |
| EI | 0.979 |
| Respiratory | 0.825 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.775394 |